JP2008543780A5 - - Google Patents

Download PDF

Info

Publication number
JP2008543780A5
JP2008543780A5 JP2008515997A JP2008515997A JP2008543780A5 JP 2008543780 A5 JP2008543780 A5 JP 2008543780A5 JP 2008515997 A JP2008515997 A JP 2008515997A JP 2008515997 A JP2008515997 A JP 2008515997A JP 2008543780 A5 JP2008543780 A5 JP 2008543780A5
Authority
JP
Japan
Prior art keywords
trifluoro
indazol
fluorophenyl
propan
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008515997A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008543780A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/022651 external-priority patent/WO2006135826A1/en
Publication of JP2008543780A publication Critical patent/JP2008543780A/ja
Publication of JP2008543780A5 publication Critical patent/JP2008543780A5/ja
Pending legal-status Critical Current

Links

JP2008515997A 2005-06-10 2006-06-08 グルココルチコイド模倣薬、それらの製造方法、医薬組成物及びそれらの使用 Pending JP2008543780A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68941205P 2005-06-10 2005-06-10
PCT/US2006/022651 WO2006135826A1 (en) 2005-06-10 2006-06-08 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof

Publications (2)

Publication Number Publication Date
JP2008543780A JP2008543780A (ja) 2008-12-04
JP2008543780A5 true JP2008543780A5 (enExample) 2009-08-13

Family

ID=37057165

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008515997A Pending JP2008543780A (ja) 2005-06-10 2006-06-08 グルココルチコイド模倣薬、それらの製造方法、医薬組成物及びそれらの使用

Country Status (17)

Country Link
US (1) US7622594B2 (enExample)
EP (1) EP1893588A1 (enExample)
JP (1) JP2008543780A (enExample)
KR (1) KR20080027828A (enExample)
CN (1) CN101193869B (enExample)
AR (1) AR058006A1 (enExample)
AU (1) AU2006257861A1 (enExample)
BR (1) BRPI0611620A2 (enExample)
CA (1) CA2610588A1 (enExample)
IL (1) IL187976A0 (enExample)
MX (1) MX2007014811A (enExample)
NZ (1) NZ564696A (enExample)
PE (1) PE20070112A1 (enExample)
RU (1) RU2007148225A (enExample)
TW (1) TW200716573A (enExample)
WO (1) WO2006135826A1 (enExample)
ZA (1) ZA200709430B (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4324480B2 (ja) * 2002-03-26 2009-09-02 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド グルココルチコイドミメティクス、その製法、医薬組成物、及び使用
NZ538932A (en) * 2002-08-29 2007-04-27 Boehringer Ingelheim Pharma 3-(sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative disease
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
PE20060776A1 (es) 2004-12-27 2006-09-26 Boehringer Ingelheim Pharma Mimeticos de glucocorticoides, metodos para prepararlos y composiciones farmaceuticas
JP2010500300A (ja) 2006-08-08 2010-01-07 サノフィ−アベンティス アリールアミノアリール−アルキル−置換イミダゾリジン−2,4−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用
JP2010508358A (ja) * 2006-11-01 2010-03-18 ブリストル−マイヤーズ スクイブ カンパニー グルココルチコイド受容体、AP−1、および/またはNF−κB活性の調節剤、並びにその使用
TW200829578A (en) 2006-11-23 2008-07-16 Astrazeneca Ab Chemical compounds 537
MX2009005264A (es) 2006-12-06 2009-05-28 Boehringer Ingelheim Int Mimeticos de glucocorticoides, metodos para su fabricacion, composiciones farmaceuticas y usos de los mismos.
JO2754B1 (en) 2006-12-21 2014-03-15 استرازينكا ايه بي Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders
WO2008079073A1 (en) * 2006-12-22 2008-07-03 Astrazeneca Ab Indazolyl sulphonamide derivatives for the treatment of glucocorticoid receptor mediated disorders
EP2134683A2 (en) * 2007-02-12 2009-12-23 Intermune, Inc. Novel inhibitors hepatitis c virus replication
US8143280B2 (en) * 2007-09-27 2012-03-27 Hoffmann-La Roche Inc. Glucocorticoid receptor antagonists
WO2009069736A1 (ja) * 2007-11-28 2009-06-04 Kyowa Hakko Kirin Co., Ltd. 含窒素化合物
UY31832A (es) * 2008-05-20 2010-01-05 Astrazeneca Ab Derivados de indazol sustituidos con fenilo y benzodioxinilo
DK2300472T3 (da) 2008-06-06 2012-04-10 Boehringer Ingelheim Int Glucocorticoidmimetika, fremgangsmåder til disses fremstilling, farmaceutiske sammensætninger samt anvendelser deraf
WO2010003624A2 (en) 2008-07-09 2010-01-14 Sanofi-Aventis Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
EP2356116A1 (en) 2008-11-20 2011-08-17 OSI Pharmaceuticals, Inc. Substituted pyrroloý2,3-b¨-pyridines and-pyrazines
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
US8138189B2 (en) * 2009-03-26 2012-03-20 Hoffman-La Roche Inc. Substituted benzene compounds as modulators of the glucocorticoid receptor
US8268820B2 (en) 2009-03-26 2012-09-18 Hoffmann-La Roche Inc. 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
SG178880A1 (en) 2009-08-26 2012-04-27 Sanofi Sa Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
US20130072495A1 (en) 2010-05-14 2013-03-21 OSI Pharmaceuticals, LLC Fused bicyclic kinase inhibitors
AR081039A1 (es) 2010-05-14 2012-05-30 Osi Pharmaceuticals Llc Inhibidores biciclicos fusionados de quinasa
EP2766349B1 (de) 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120054A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120055A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683704B1 (de) 2011-03-08 2014-12-17 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
JP2014513724A (ja) 2011-05-16 2014-06-05 オーエスアイ・ファーマシューティカルズ,エルエルシー 融合二環キナーゼ阻害剤
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
GB201321740D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
CN104829591B (zh) * 2015-04-27 2017-05-03 梯尔希(南京)药物研发有限公司 氘代匹莫齐特的制备方法
WO2017161518A1 (en) * 2016-03-23 2017-09-28 Astrazeneca Ab New physical form
WO2017172368A1 (en) 2016-03-31 2017-10-05 Oncternal Therapeutics, Inc. Indoline analogs and uses thereof
BR112021002207A2 (pt) 2018-08-10 2021-05-04 Diapin Therapeutics, Llc tri-peptídeos e tratamento de distúrbios metabólicos, cardiovasculares e inflamatórios
US12240855B2 (en) 2019-03-06 2025-03-04 Daiichi Sankyo Company, Limited Pyrrolopyrazole derivative
IL298957A (en) * 2020-06-22 2023-02-01 Corcept Therapeutics Inc Quaternary indazole glucocorticoid receptor antagonists
US20250136548A1 (en) * 2022-01-20 2025-05-01 Terran Biosciences Inc. Functionalized alkylamines
CN117069629B (zh) * 2023-07-27 2026-03-24 五邑大学 一种含硫乙酰胺类化合物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19856475A1 (de) 1998-11-27 2000-05-31 Schering Ag Nichtsteroidale Entzündungshemmer
EP1467982B8 (en) 2002-01-14 2007-04-11 Boehringer Ingelheim Pharmaceuticals Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
EP1490317A1 (en) 2002-03-26 2004-12-29 Boehringer Ingelheim Pharmaceuticals Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
JP4324480B2 (ja) * 2002-03-26 2009-09-02 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド グルココルチコイドミメティクス、その製法、医薬組成物、及び使用
EP1583745A1 (en) * 2003-01-03 2005-10-12 Boehringer Ingelheim Pharmaceuticals Inc. 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
UY28526A1 (es) * 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
TW200523503A (en) * 2003-09-29 2005-07-16 Sony Corp Backlight, light guiding plate, method for manufacturing diffusion plate and light guiding plate, and liquid crystal display device

Similar Documents

Publication Publication Date Title
RU2007148225A (ru) Глюкокортикоидные миметики, способы их получения, фармацевтические композиции и их применение
US9732066B2 (en) Heterocyclic derivative and pharmaceutical drug
TWI382015B (zh) 苯、吡啶及噠嗪衍生物
US20100029598A1 (en) Extended Benzamide Derivatives as Modulators of the EP2 Receptor
CA2478156A1 (en) Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
JP2013538801A5 (enExample)
ME01421B (me) 5-supstituisani derivati kinazolinona kao protivtumorska sredstva
RU2011127232A (ru) Апоптоз-индуцирующие средства для лечения рака и иммунных и аутоиммунных заболеваний
RU2010137114A (ru) Амидные производные как позитивные аллостерические модуляторы и способы их применения
TW200804345A (en) Substituted benzimidazoles and methods of preparation
TW201120010A (en) Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
AU2007279079A1 (en) Compounds having CRTH2 antagonist activity
RU2013123274A (ru) Аминопирролидиназетидиндиамиды как ингибиторы моноацилглицеринлипазы
WO2002060392A2 (en) Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
AR072262A1 (es) COMBINACION -408, QUE COMPRENDE N-CICLOHEXIL-N3-[2-(3-FLUOROFENIL)ETIL]-N-(2-{[2-(4-HIDROXI-2-OXO-2,3-DIHIDRO-1,3-BENZOTIAZOL-7-IL)ETIL]AMINO}ETIL- beta-ALANINAMIDA.USO. METODO. CONJUNTO DE ELEMENTOS. COMPOSICION FARMACEUTICA. INTERMEDIARIO.
KR20010006487A (ko) 조합된 5ht1a, 5ht1b 및 5ht1d 수용체 길항 활성을 갖는 인돌 유도체
CN104302287B (zh) 作为蛋白质激酶抑制剂的吲哚啉‑2‑酮衍生物
CA2586179A1 (en) Sulfonyl benzimidazole derivatives
JP2016540045A5 (enExample)
JP2016536348A5 (enExample)
JP2010006813A (ja) うつ病および/又は不安症を治療するためのgal3受容体アンタゴニストの使用、およびこのような方法において有用な化合物
RU2007115548A (ru) Новые сульфонамидные производные в качестве модуляторов глюкокортикоидного рецептора для лечения воспалительных заболеваний
US7465750B2 (en) Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds useful in such methods
ZA200300562B (en) 4-,5-,6- and 7-indole derivatives useful for the treatment of CNS disorders.